Tracking blood thinner use in people with AF or blood clots
Part of Heart & circulation clinical trials.
This registry study looks at how people with atrial fibrillation (AF) or blood clots (VTE) use blood thinners, especially NOACs, over time. It may help doctors better understand real-world patterns of treatment and outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with AF or with a blood clot called VTE (including new or returning clots)
- Your diagnosis was confirmed using heart rhythm testing (like ECG, Holter, or a device) or medical evaluation for clots
- You have been taking an “oral blood thinner” (NOAC or warfarin/VKA) in the last 3 months
- Your AF is not caused by a temporary/reversible issue (like thyroid problems or after surgery)
- Your AF is not due to specific heart valve disease (like rheumatic mitral stenosis) or a mechanical heart valve
- You are not currently joining another AF or VTE clinical trial, and your medical information is complete
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether the amount of a blood thinner (NOAC) in your bloodstream is linked to health outcomes. It may help doctors better understand how to monitor and use these medicines safely.
This study looks at how often and how well doctors use oral blood-thinner medicines for people with atrial fibrillation (AF) or atrial flutter (a related heart rhythm problem). It aims to see whether “provider profiling” (using clinic patterns to guide improvements) can support safer, more consistent use of these medicines.
This study builds a registry by asking adults who take blood thinners (anticoagulants) about their experiences. It may help improve care by learning how these medicines are used in real life.
This trial tests whether taking a blood thinner can lower the risk of stroke in people who had atrial fibrillation (an irregular heartbeat) that happened temporarily around a stressful illness or surgery. It looks especially at people at higher risk for stroke after that episode.
This trial tests how well blood thinners (anticoagulants) work to dissolve clots in the heart of people with atrial fibrillation (an irregular heartbeat). It aims to find the best treatment for these clots before more serious complications occur.
This study follows people with atrial fibrillation to see how well blood-thinning medications work and what outcomes they experience over time. It aims to improve treatment guidance for patients with this common heart rhythm condition.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.